Sanuwave Health Debt to Equity Ratio 2010-2024 | SNWV
Current and historical debt to equity ratio values for Sanuwave Health (SNWV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sanuwave Health debt/equity for the three months ending September 30, 2024 was 0.00.
| Sanuwave Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $0.08B | $-0.06B | -1.36 |
| 2024-06-30 | $0.06B | $-0.04B | -1.53 |
| 2024-03-31 | $0.07B | $-0.05B | -1.49 |
| 2023-12-31 | $0.07B | $-0.04B | -1.52 |
| 2023-09-30 | $0.09B | $-0.07B | -1.31 |
| 2023-06-30 | $0.08B | $-0.06B | -1.32 |
| 2023-03-31 | $0.07B | $-0.05B | -1.33 |
| 2022-12-31 | $0.06B | $-0.04B | -1.49 |
| 2022-09-30 | $0.05B | $-0.03B | -1.61 |
| 2022-06-30 | $0.05B | $-0.03B | -1.55 |
| 2022-03-31 | $0.05B | $-0.04B | -1.46 |
| 2021-12-31 | $0.06B | $-0.04B | -1.48 |
| 2021-09-30 | $0.05B | $-0.03B | -1.65 |
| 2021-06-30 | $0.05B | $-0.03B | -1.78 |
| 2021-03-31 | $0.04B | $-0.02B | -2.22 |
| 2020-12-31 | $0.04B | $-0.01B | -2.68 |
| 2020-09-30 | $0.04B | $-0.01B | -4.61 |
| 2020-06-30 | $0.02B | $-0.02B | -1.23 |
| 2020-03-31 | $0.02B | $-0.01B | -1.25 |
| 2019-12-31 | $0.01B | $-0.01B | -1.34 |
| 2019-09-30 | $0.02B | $-0.01B | -1.12 |
| 2019-06-30 | $0.02B | $-0.02B | -1.09 |
| 2019-03-31 | $0.02B | $-0.02B | -1.09 |
| 2018-12-31 | $0.02B | $-0.02B | -1.08 |
| 2018-09-30 | $0.01B | $-0.01B | -1.05 |
| 2018-06-30 | $0.02B | $-0.02B | -1.09 |
| 2018-03-31 | $0.02B | $-0.01B | -1.07 |
| 2017-12-31 | $0.01B | $-0.01B | -1.13 |
| 2017-09-30 | $0.01B | $-0.01B | -1.06 |
| 2017-06-30 | $0.01B | $-0.01B | -1.08 |
| 2017-03-31 | $0.01B | $-0.01B | -1.13 |
| 2016-12-31 | $0.01B | $-0.01B | -1.15 |
| 2016-09-30 | $0.01B | $-0.01B | -1.20 |
| 2016-06-30 | $0.01B | $-0.01B | -1.12 |
| 2016-03-31 | $0.01B | $-0.01B | -1.24 |
| 2015-12-31 | $0.01B | $-0.01B | -1.16 |
| 2015-09-30 | $0.01B | $-0.01B | -1.29 |
| 2015-06-30 | $0.01B | $-0.00B | -1.61 |
| 2015-03-31 | $0.01B | $-0.00B | -2.30 |
| 2014-12-31 | $0.01B | $-0.00B | -4.01 |
| 2014-09-30 | $0.01B | $0.00B | -15.03 |
| 2014-06-30 | $0.01B | $0.00B | 6.04 |
| 2014-03-31 | $0.01B | $0.00B | 4.00 |
| 2013-12-31 | $0.01B | $-0.01B | -1.26 |
| 2013-09-30 | $0.01B | $-0.01B | -1.29 |
| 2013-06-30 | $0.01B | $-0.01B | -1.14 |
| 2013-03-31 | $0.01B | $-0.01B | -1.21 |
| 2012-12-31 | $0.01B | $-0.01B | -1.28 |
| 2012-09-30 | $0.01B | $-0.01B | -1.41 |
| 2012-06-30 | $0.01B | $-0.00B | -1.79 |
| 2012-03-31 | $0.01B | $-0.00B | -2.48 |
| 2011-12-31 | $0.01B | $-0.00B | -5.01 |
| 2011-09-30 | $0.01B | $0.00B | 23.47 |
| 2011-06-30 | $0.01B | $0.00B | 3.82 |
| 2011-03-31 | $0.01B | $-0.01B | -1.58 |
| 2010-12-31 | $0.01B | $-0.01B | -1.29 |
| 2010-09-30 | $0.02B | $-0.01B | -1.28 |
| 2010-06-30 | $0.02B | $-0.01B | -1.36 |
| 2010-03-31 | $0.01B | $-0.01B | -1.59 |
| 2009-12-31 | $0.01B | $-0.01B | -2.00 |
| 2009-09-30 | $0.01B | $-0.00B | -3.08 |
| 2009-06-30 | $0.00B | $0.00B | -1.01 |
| 2009-03-31 | $0.00B | $0.00B | -1.06 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.173B | $0.020B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $196.653B | 25.08 |
| Stryker (SYK) | United States | $142.804B | 32.18 |
| Boston Scientific (BSX) | United States | $132.807B | 38.18 |
| EssilorLuxottica (ESLOY) | France | $110.936B | 0.00 |
| Medtronic (MDT) | Ireland | $105.763B | 15.71 |
| Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.076B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.052B | 19.22 |
| ResMed (RMD) | United States | $35.014B | 28.77 |
| Terumo (TRUMY) | Japan | $29.635B | 41.85 |
| Koninklijke Philips (PHG) | Netherlands | $24.241B | 18.55 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.249B | 13.53 |
| Insulet (PODD) | United States | $18.893B | 75.23 |
| Baxter (BAX) | United States | $15.481B | 10.07 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.161B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.045B | 40.41 |
| Bio-Rad Laboratories (BIO) | United States | $9.415B | 32.00 |
| Demant (WILYY) | Denmark | $8.300B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.467B | 15.03 |
| Haemonetics (HAE) | United States | $4.078B | 19.90 |
| Prestige Consumer Healthcare (PBH) | United States | $4.066B | 20.22 |
| ICU Medical (ICUI) | United States | $3.958B | 37.68 |
| Perrigo (PRGO) | Ireland | $3.745B | 11.02 |
| Envista Holdings (NVST) | United States | $3.351B | 24.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.928B | 18.78 |
| QuidelOrtho (QDEL) | United States | $2.781B | 17.90 |
| Neogen (NEOG) | United States | $2.633B | 30.37 |
| LeMaitre Vascular (LMAT) | United States | $2.264B | 55.02 |
| Green Thumb Industries (GTBIF) | United States | $1.710B | 29.93 |
| AtriCure (ATRC) | United States | $1.544B | 0.00 |
| InMode (INMD) | Israel | $1.534B | 9.22 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.432B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.285B | 9.18 |
| BioLife Solutions (BLFS) | United States | $1.239B | 0.00 |
| Owens & Minor (OMI) | United States | $1.075B | 8.40 |
| CeriBell (CBLL) | United States | $1.047B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.031B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.918B | 16.19 |
| Evolus (EOLS) | United States | $0.729B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.635B | 28.07 |
| Capricor Therapeutics (CAPR) | United States | $0.603B | 0.00 |
| Surmodics (SRDX) | United States | $0.573B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.488B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Omeros (OMER) | United States | $0.442B | 0.00 |
| Quanterix (QTRX) | United States | $0.410B | 0.00 |
| ZimVie (ZIMV) | United States | $0.379B | 31.93 |
| Biote (BTMD) | United States | $0.346B | 7.58 |
| Viemed Healthcare (VMD) | United States | $0.340B | 32.37 |
| Canopy Growth (CGC) | Canada | $0.339B | 0.00 |
| Valneva SE (VALN) | France | $0.319B | 0.00 |
| Cerus (CERS) | United States | $0.318B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.303B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Zynex (ZYXI) | United States | $0.259B | 54.27 |
| High Tide (HITI) | Canada | $0.257B | 106.33 |
| Aurora Cannabis (ACB) | Canada | $0.236B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.213B | 14.73 |
| MacroGenics (MGNX) | United States | $0.201B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.187B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.176B | 0.00 |
| Brainsway (BWAY) | Israel | $0.157B | 94.20 |
| FitLife Brands (FTLF) | United States | $0.156B | 19.65 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jin Medical (ZJYL) | China | $0.121B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.119B | 0.00 |
| Veru (VERU) | United States | $0.106B | 0.00 |
| Exagen (XGN) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.098B | 11.09 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| Modular Medical (MODD) | United States | $0.055B | 0.00 |
| Safety Shot (SHOT) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.044B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.93 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |